Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology

作者：Ranjana H. Advani, C. Kelsey, Philippe Armand, Celeste M. Bello, Cecil Mayra Benitez, David Alan Bond, Weina Chen, Sheen Cherian, Magdalena Czader, Bouthaina Dabaja, Megan E. Daly, Zachary AK Frosch, L. I. Gordon, Neil Hansen, Alex Francisco Herrera, Ephraim P. Hochberg, Richard T. Hoppe, Iris Isufi, Patrick B. Johnston, Kara M Kelly, Vaishalee Padgaonkar Kenkre, Justin Paul Kline, R. Lynch, Jonathan McConathy, David Morgan, Alex Niu, Suman Paul, Rachel Rabinovitch, Ali Salavati, Dahlia Sano, Harsh Shah, Michael Alexander Spinner, J. Svoboda, Jane N. Winter, Joachim Yahalom, Joanna Chensi Yang, Sarah E. Montgomery, Katie Stehman · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2026 · DOI：10.6004/jnccn.2026.0006 · 被引用次数：9 · 研究领域：Lymphoma Diagnosis and Treatment、Cutaneous lymphoproliferative disorders research、Lymphadenopathy Diagnosis and Analysis

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.